Drug FDA Class I Ongoing cGMP deviation

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

HANDELNINE GLOBAL LLC Published Feb 11, 2026

Risk level

Class I

Dangerous or defective — could cause serious health problems or death.

Severity score 75/100

What should you do?

Check whether you have this product, using the lot codes, UPCs, and dates listed below.
Do not eat, serve, or sell the affected product.
Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
Contact HANDELNINE GLOBAL LLC or your place of purchase with questions, and see the source record below for full details.

Reason for recall

CGMP Deviations: product found to contain lead.

Hazards

Lead · primary

Affected products (1)

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

4 bottles /30 capsules each

Lot codes: CAM040, CAL079-N

Code info: Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028

Affected areas

New York

Timeline

Initiated

Dec 22, 2025
Published

Feb 11, 2026

Recall number: D-0332-2026
Agency: U.S. Food and Drug Administration
Country: US

Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.